Zhang Y, Wang Z, Peng J, Gerner S, Yin S, Jiang Y (2021)
Publication Type: Journal article
Publication year: 2021
Book Volume: 337
Article Number: 113585
DOI: 10.1016/j.expneurol.2020.113585
Individuals suffering from traumatic brain injury (TBI) often experience the activation of the immune system, resulting in declines in cognitive and neurological function after brain injury. Despite decades of efforts, approaches for clinically effective treatment are sparse. Evidence on the association between current therapeutic strategies and clinical outcomes after TBI is limited to poorly understood mechanisms. For decades, an increasing number of studies suggest that the gut-brain axis (GBA), a bidirectional communication system between the central nervous system (CNS) and the gastrointestinal tract, plays a critical role in systemic immune response following neurological diseases. In this review, we detail current knowledge of the immune pathologies of GBA after TBI. These processes may provide a new therapeutic target and rehabilitation strategy developed and used in clinical treatment of TBI patients.
APA:
Zhang, Y., Wang, Z., Peng, J., Gerner, S., Yin, S., & Jiang, Y. (2021). Gut microbiota-brain interaction: An emerging immunotherapy for traumatic brain injury. Experimental Neurology, 337. https://doi.org/10.1016/j.expneurol.2020.113585
MLA:
Zhang, Yuxuan, et al. "Gut microbiota-brain interaction: An emerging immunotherapy for traumatic brain injury." Experimental Neurology 337 (2021).
BibTeX: Download